IELASI, LUCA
IELASI, LUCA
A case of Leishmania infection with focal splanchnic involvement without systemic symptoms: a potential anti-inflammatory role for vitamin D
2022 Zaghi, I; Ielasi, L; Stagni, B; Cascavilla, A; Ferri, S; Ambrosini, V; Riefolo, M; Varani, S
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib
2018 Ielasi, L.; Sansone, V.; Granito, A.; Benevento, F.; De Lorenzo, S.; Tovoli, F.*
An update on atezolizumab for hepatocellular carcinoma
2021 Ielasi L.; Sansone V.; Forgione A.; Granito A.; Benevento F.; Tovoli F.
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders
2021 Ielasi L.; Tovoli F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Sansone V.; Marasco G.; Piscaglia F.; Granito A.
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3)
2020 Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A.
Experience with regorafenib in the treatment of hepatocellular carcinoma
2021 Granito A.; Forgione A.; Marinelli S.; Renzulli M.; Ielasi L.; Sansone V.; Benevento F.; Piscaglia F.; Tovoli F.
Hot topics in hepatocellular carcinoma
2019 Ielasi L.; Goio E.; Tovoli F.
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience
2021 Rimini M.; Yoo C.; Lonardi S.; Masi G.; Granito A.; Bang Y.; Rizzato M.D.; Vivaldi C.; Ielasi L.; Kim H.-D.; Bergamo F.; Salani F.; Leoni S.; Ryoo B.-Y.; Ryoo M.-H.; Burgio V.; Cascinu S.; Casadei-Gardini A.
Lenvatinib mesylate to treat hepatocellular carcinoma
2019 Ielasi L.; Tovoli F.; Piscaglia F.
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery
2020 Elisabetta Goio; Luca Ielasi; Francesca Benevento; Matteo Renzulli; Francesco Tovoli
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients
2019 Tovoli F.; Ielasi L.; Casadei-Gardini A.; Granito A.; Foschi F.G.; Rovesti G.; Negrini G.; Orsi G.; Renzulli M.; Piscaglia F.
Natural history of hypovascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced mr imaging in cirrhotic patients during surveillance program
2017 Ielasi L, Granito A, Renzulli M, Galassi M, Guidetti E, Piscaglia F, Golfieri R, Bolondi L
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments
2023 Tovoli, Francesco; Pallotta, Dante Pio; Sansone, Vito; Iavarone, Massimo; De Giorgio, Massimo; Ielasi, Luca; Di Costanzo, Giovan Giuseppe; Giuffrida, Paolo; Sacco, Rodolfo; Pressiani, Tiziana; Di Donato, Maria Francesca; Trevisani, Franco; Fagiuoli, Stefano; Piscaglia, Fabio; Granito, Alessandro
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
2020 Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A.
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib
2021 Rimini M.; Yoo C.; Lonardi S.; Masi G.; Piscaglia F.; Kim H.-D.; Rizzato M.D.; Salani F.; Ielasi L.; Forgione A.; Bang Y.; Solda C.; Catanese S.; Sansone V.; Ryu M.-H.; Ryoo B.-Y.; Burgio V.; Cucchetti A.; Cascinu S.; Casadei-Gardini A.
Treatment of combined hepatocellular and cholangiocarcinoma
2020 Leoni S.; Sansone V.; De Lorenzo S.; Ielasi L.; Tovoli F.; Renzulli M.; Golfieri R.; Spinelli D.; Piscaglia F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A case of Leishmania infection with focal splanchnic involvement without systemic symptoms: a potential anti-inflammatory role for vitamin D | Zaghi, I; Ielasi, L; Stagni, B; Cascavilla, A; Ferri, S; Ambrosini, V; Riefolo, M; Varani, S | 2022-01-01 | ACTA CLINICA BELGICA | - | 1.01 Articolo in rivista | - |
| An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib | Ielasi, L.; Sansone, V.; Granito, A.; Benevento, F.; De Lorenzo, S.; Tovoli, F.* | 2018-01-01 | DRUGS OF TODAY | - | 1.01 Articolo in rivista | - |
| An update on atezolizumab for hepatocellular carcinoma | Ielasi L.; Sansone V.; Forgione A.; Granito A.; Benevento F.; Tovoli F. | 2021-01-01 | DRUGS OF TODAY | - | 1.01 Articolo in rivista | - |
| Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders | Ielasi L.; Tovoli F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Sa...nsone V.; Marasco G.; Piscaglia F.; Granito A. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-06376.pdf |
| Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) | Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Graman...tieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A. | 2020-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Experience with regorafenib in the treatment of hepatocellular carcinoma | Granito A.; Forgione A.; Marinelli S.; Renzulli M.; Ielasi L.; Sansone V.; Benevento F.; Piscagli...a F.; Tovoli F. | 2021-01-01 | THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | - | 1.01 Articolo in rivista | Granito 2021 Regorafenib.pdf |
| Hot topics in hepatocellular carcinoma | Ielasi L.; Goio E.; Tovoli F. | 2019-01-01 | TRANSLATIONAL CANCER RESEARCH | - | 1.01 Articolo in rivista | 58. Hot topics editorial.pdf |
| Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience | Rimini M.; Yoo C.; Lonardi S.; Masi G.; Granito A.; Bang Y.; Rizzato M.D.; Vivaldi C.; Ielasi L.;... Kim H.-D.; Bergamo F.; Salani F.; Leoni S.; Ryoo B.-Y.; Ryoo M.-H.; Burgio V.; Cascinu S.; Casadei-Gardini A. | 2021-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Lenvatinib mesylate to treat hepatocellular carcinoma | Ielasi L.; Tovoli F.; Piscaglia F. | 2019-01-01 | DRUGS OF TODAY | - | 1.01 Articolo in rivista | - |
| Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery | Elisabetta Goio; Luca Ielasi; Francesca Benevento; Matteo Renzulli; Francesco Tovoli | 2020-01-01 | HEPATIC ONCOLOGY | - | 1.01 Articolo in rivista | hep-2020-0014.pdf |
| Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients | Tovoli F.; Ielasi L.; Casadei-Gardini A.; Granito A.; Foschi F.G.; Rovesti G.; Negrini G.; Orsi G....; Renzulli M.; Piscaglia F. | 2019-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Natural history of hypovascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced mr imaging in cirrhotic patients during surveillance program | Ielasi L, Granito A, Renzulli M, Galassi M, Guidetti E, Piscaglia F, Golfieri R, Bolondi L | 2017-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments | Tovoli, Francesco; Pallotta, Dante Pio; Sansone, Vito; Iavarone, Massimo; De Giorgio, Massimo; Ie...lasi, Luca; Di Costanzo, Giovan Giuseppe; Giuffrida, Paolo; Sacco, Rodolfo; Pressiani, Tiziana; Di Donato, Maria Francesca; Trevisani, Franco; Fagiuoli, Stefano; Piscaglia, Fabio; Granito, Alessandro | 2023-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma | Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Graman...tieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A. | 2020-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib | Rimini M.; Yoo C.; Lonardi S.; Masi G.; Piscaglia F.; Kim H.-D.; Rizzato M.D.; Salani F.; Ielasi ...L.; Forgione A.; Bang Y.; Solda C.; Catanese S.; Sansone V.; Ryu M.-H.; Ryoo B.-Y.; Burgio V.; Cucchetti A.; Cascinu S.; Casadei-Gardini A. | 2021-01-01 | HEPATOLOGY RESEARCH | - | 1.01 Articolo in rivista | - |
| Treatment of combined hepatocellular and cholangiocarcinoma | Leoni S.; Sansone V.; De Lorenzo S.; Ielasi L.; Tovoli F.; Renzulli M.; Golfieri R.; Spinelli D.;... Piscaglia F. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-00794-v2.pdf |